Elastrin Therapeutics secures $10 million of funding for its calcification removal platform
Forever Healthy Foundation - 07-Apr-2022Initially targeting stiffened arteries in cardiovascular disease, this could have wider implications
The Live Forever Club is evolving. Subscribe to the newsletter to be the first to hear about this important change.
Co-founder at TGenTech, Elastrin Therapeutics and Professor of Bioengineering at Clemson University
Naren Vyavahare is a Co-founder at TGenTech, Elastrin Therapeutics Inc., and Professor of Bioengineering at Clemson University, Clemson. Dr. Vyavahare is a Director of NIH funded South Carolina Bioengineering Center of Regeneration and Formation of Tissues (SC BioCRAFT). He has graduated 15 Ph.D. students and 21 MS students as a major advisor. Dr. Vyavahare is the recipient of many awards including; McQueen Quattlebaum Faculty Excellence Award, Clemson University, and Alumni award for outstanding achievement in research, Clemson University. He is a Fellow of the American Institute of Medical and Biological Engineering (AIMBE). Prior to joining Clemson, Dr. Vyavahare served as a Research Assistant Professor at the University of Pennsylvania School of Medicine, and the University of Michigan.
Visit website: https://www.clemson.edu/cecas/departments/bioe/people/faculty-staff/directory/vyavahare.html
See alsoDetails last updated 06-Mar-2021
Initially targeting stiffened arteries in cardiovascular disease, this could have wider implications
Advancing technologies for tissue and organ rejuvenation with seed funding from Kizoo